S., P., S., Z., W.-L., C., G.R., F., S.K., S., R., F., . . . I.M., J. (2014). Randomized trial of albinterferon alfa-2b every 4 weeks for chronic hepatitis C virus genotype 2/3.
Chicago Style CitationS., Pianko, et al. Randomized Trial of Albinterferon Alfa-2b Every 4 Weeks for Chronic Hepatitis C Virus Genotype 2/3. 2014.
MLA CitationS., Pianko, et al. Randomized Trial of Albinterferon Alfa-2b Every 4 Weeks for Chronic Hepatitis C Virus Genotype 2/3. 2014.
Warning: These citations may not always be 100% accurate.